Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Low Transforming Growth Factor-β3 Expression Predicts Tumor Malignancy in Meningiomas.

Ma J, Li D, Chen Y, Zhang Y, Song L, Tian K, Yang Y, Chen L, Weng J, Cao X, Hao S, Wang L, Wu Z, Zhang J.

World Neurosurg. 2019 Jan 28. pii: S1878-8750(19)30175-5. doi: 10.1016/j.wneu.2019.01.077. [Epub ahead of print]

PMID:
30703597
2.

High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.

Ma J, Tian K, Du J, Wu Z, Wang L, Zhang J.

J Neurosurg. 2019 Jan 11:1-10. doi: 10.3171/2018.8.JNS181580. [Epub ahead of print]

PMID:
30641849
3.

A Novel MRI-Based Radiomics Model for Predicting Recurrence in Chordoma.

Wei W, Wang K, Tian K, Liu Z, Wang L, Zhang J, Tang Z, Wang S, Dong D, Zang Y, Gao Y, Wu Z, Tian J.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:139-142. doi: 10.1109/EMBC.2018.8512207.

PMID:
30440358
4.

Analysis of variants at LGALS3 single nucleotide polymorphism loci in skull base chordoma.

Tian K, Wang L, Wang K, Ma J, Li D, Yang Y, Jia G, Wu Z, Zhang L, Zhang J.

Oncol Lett. 2018 Jul;16(1):1312-1320. doi: 10.3892/ol.2018.8780. Epub 2018 May 22.

5.

Effect comparisons among treatment measures on progression-free survival in patients with skull base chordomas: a retrospective study of 234 post-surgical cases.

Wang L, Tian K, Ma J, Wang K, Jia G, Wu Z, Zhang L, Zhang J.

Acta Neurochir (Wien). 2017 Oct;159(10):1803-1813. doi: 10.1007/s00701-017-3261-6. Epub 2017 Jul 11.

PMID:
28699066
6.

In Reply to the Letter to the Editor Regarding "Expression of Cathepsin K in Skull Base Chordoma".

Tian K, Wang L, Zhang J.

World Neurosurg. 2017 Jul;103:931. doi: 10.1016/j.wneu.2017.04.113. No abstract available.

PMID:
28672710
7.

Expression of Cathepsin K in Skull Base Chordoma.

Tian K, Ma J, Wang L, Wang K, Li D, Hao S, Yang Y, Du J, Jia G, Zhang L, Wu Z, Zhang J.

World Neurosurg. 2017 May;101:396-404. doi: 10.1016/j.wneu.2017.02.012. Epub 2017 Feb 12.

PMID:
28216213
8.

Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.

Wang L, Wu Z, Tian K, Wang K, Li D, Ma J, Jia G, Zhang L, Zhang J.

J Neurosurg. 2017 Dec;127(6):1257-1267. doi: 10.3171/2016.9.JNS16559. Epub 2017 Jan 6.

PMID:
28059654
9.

Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients.

Tian K, Zhang H, Ma J, Wang K, Ru X, Du J, Jia G, Zhang L, Wu Z, Zhang J, Wang L.

World Neurosurg. 2017 Jan;97:39-48. doi: 10.1016/j.wneu.2016.09.055. Epub 2016 Sep 23.

PMID:
27671886
10.

Factors for tumor progression in patients with skull base chordoma.

Wang L, Tian K, Wang K, Ma J, Ru X, Du J, Jia G, Zhang L, Wu Z, Zhang J.

Cancer Med. 2016 Sep;5(9):2368-77. doi: 10.1002/cam4.834. Epub 2016 Aug 21.

11.

Analysis of Clinical Features and Outcomes of Skull Base Chordoma in Different Age-Groups.

Tian K, Wang L, Wang K, Ma J, Li D, Hao S, Yang Y, Du J, Jia G, Zhang L, Wu Z, Zhang J.

World Neurosurg. 2016 Aug;92:407-417. doi: 10.1016/j.wneu.2016.05.035. Epub 2016 May 27.

PMID:
27237421
12.

Bone invasiveness is associated with prognosis in clivus chordomas.

Wang K, Wang L, Wu Z, Tian K, Ren C, Jia G, Zhang L, Zhang J.

J Clin Neurosci. 2016 May;27:147-52. doi: 10.1016/j.jocn.2015.05.073. Epub 2016 Jan 22.

PMID:
26810468
13.

Familial chordoma: A case report and review of the literature.

Wang KE, Wu Z, Tian K, Wang L, Hao S, Zhang L, Zhang J.

Oncol Lett. 2015 Nov;10(5):2937-2940. Epub 2015 Sep 9.

14.

T gene isoform expression pattern is significantly different between chordomas and notochords.

Wang K, Hu Q, Wang L, Chen W, Tian K, Cao C, Wu Z, Jia G, Zhang L, Zeng C, Zhang J.

Biochem Biophys Res Commun. 2015 Nov 13;467(2):261-7. doi: 10.1016/j.bbrc.2015.09.178. Epub 2015 Oct 3.

PMID:
26435504
15.

Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas.

Wang K, Tian K, Wang L, Wu Z, Ren C, Hao S, Feng J, Li J, Wan H, Jia G, Zhang L, Zhang J.

Mol Med Rep. 2015 Sep;12(3):4298-4304. doi: 10.3892/mmr.2015.3976. Epub 2015 Jun 22.

16.

Experimental study on differences in clivus chordoma bone invasion: an iTRAQ-based quantitative proteomic analysis.

Wu Z, Wang L, Guo Z, Wang K, Zhang Y, Tian K, Zhang J, Sun W, Yu C.

PLoS One. 2015 Mar 20;10(3):e0119523. doi: 10.1371/journal.pone.0119523. eCollection 2015.

17.

Surgical resection of upper-middle clivus chordomas via a modified anterior transpetrous approach.

Wang K, Wang L, Tian K, Xiao X, Wu Z, Jia G, Zhang L, Zhang J.

Clin Neurol Neurosurg. 2015 Mar;130:20-5. doi: 10.1016/j.clineuro.2014.12.016. Epub 2014 Dec 31.

PMID:
25576881
18.

WRN Cys1367Arg polymorphism is not associated with skull base chordoma.

Wang K, Wang L, Feng J, Hao S, Tian K, Wu Z, Zhang L, Jia G, Wan H, Zhang J.

Biomed Rep. 2014 Jul;2(4):521-524. Epub 2014 May 15.

19.

The brachyury Gly177Asp SNP is not associated with a risk of skull base chordoma in the Chinese population.

Wu Z, Wang K, Wang L, Feng J, Hao S, Tian K, Zhang L, Jia G, Wan H, Zhang J.

Int J Mol Sci. 2013 Oct 25;14(11):21258-65. doi: 10.3390/ijms141121258.

20.

Clinical and pathological features of intradural retroclival chordoma.

Wang L, Wu Z, Tian K, Li G, Zhang J.

World Neurosurg. 2014 Nov;82(5):791-8. doi: 10.1016/j.wneu.2012.12.037. Epub 2013 Feb 13.

PMID:
23416632

Supplemental Content

Loading ...
Support Center